Back
Tilray Brands Vs. Acasti Pharma Industry Stock Comparison
Sell
26
TLRY
Tilray Brands
Last Price:
1.68
Seasonality Move:
17.5%
Buy
59
ACST
Acasti Pharma
Last Price:
2.95
Seasonality Move:
-0.97%
Sell
26
Tilray Brands (TLRY)
is a Sell
Is Tilray Brands a Buy, Sell or Hold?
- The current Tilray Brands [TLRY] share price is $1.62. The Score for TLRY is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- TLRY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Acasti Pharma (ACST)
is a Buy
Is Acasti Pharma a Buy, Sell or Hold?
- The current Acasti Pharma [ACST] share price is $3.10. The Score for ACST is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- ACST is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TLRY Stock Price Chart
What is Tilray Brands's stock price today?
-
The Tilray Brands share price today is $1.62
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TLRY is experiencing selling pressure, which indicates risk of future bearish movement.
ACST Stock Price Chart
What is Acasti Pharma's stock price today?
-
The Acasti Pharma share price today is $3.10
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACST is experiencing selling pressure, which indicates risk of future bearish movement.
TLRY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.07 | Sell |
Relative Strength Index (14 RSI): | 30.3 | Sell |
Chaikin Money Flow: | -8610255 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.69 - 1.85) | Sell |
Bollinger Bands (100): | (1.65 - 2.15) | Sell |
ACST Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.09 | Buy |
Relative Strength Index (14 RSI): | 51.92 | Buy |
Chaikin Money Flow: | -13785 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.74 - 3.22) | Buy |
Bollinger Bands (100): | (2.73 - 3.41) | Buy |
TLRY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.68 | Sell |
20-day SMA: | 1.75 | Sell |
50-day SMA: | 1.85 | Sell |
200-day SMA: | 1.99 | Sell |
8-day EMA: | 1.68 | Sell |
20-day EMA: | 1.75 | Sell |
50-day EMA: | 1.84 | Sell |
200-day EMA: | 2.04 | Sell |
ACST Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.22 | Sell |
20-day SMA: | 3.05 | Buy |
50-day SMA: | 2.94 | Buy |
200-day SMA: | 2.72 | Buy |
8-day EMA: | 3.18 | Sell |
20-day EMA: | 3.09 | Buy |
50-day EMA: | 3.02 | Buy |
200-day EMA: | 2.93 | Buy |
Tilray Brands Earnings Growth & TLRY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.02 per share, an increase this year of $0.81 per share, and an increase next year of $0.03 per share.
Acasti Pharma Earnings Growth & ACST Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.10 per share, an increase this year of $1.16 per share, and an increase next year of $0.34 per share.
Tilray Brands Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Acasti Pharma Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |